Cytokind, Inc.
PrivateLast Round
VC Round
Jun 13, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cytokind, Inc. operates in Healthcare & Life Sciences and is based in New Hampshire.
Cytokind, Inc. is a medical device and drug discovery company that develops and distributes narrowband UVB phototherapy devices to treat autoimmune and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cytokind, Inc. Comparables
Compare Cytokind, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Solarc Systems Inc. | 87% | |
| UVBioTek | 85% | |
| National Biological Corporation | 81% |
For institutional investors. Book with your work email.
Cytokind, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 111% MoM, reaching 5.5K.
- Jan 20, 2026
Monthly visitors increased 70% MoM.
For institutional investors. Book with your work email.
Cytokind, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cytokind, Inc.'s valuation, stock price, and market status.
Is Cytokind, Inc. a public or private company?
Cytokind, Inc. is a private company.
What is the current stock price of Cytokind, Inc.?
Cytokind, Inc. is a private company, so its shares have no public market price. Caplight tracks Cytokind, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cytokind, Inc. worth (valuation)?
Valuation information for Cytokind, Inc. is not publicly available.
Can I buy Cytokind, Inc. stock?
Cytokind, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cytokind, Inc.'s last funding round?
Cytokind, Inc.'s most recent funding round was VC Round on June 13, 2025.
Who are the main investors in Cytokind, Inc.?
Investor information for Cytokind, Inc. is not publicly disclosed.
Will Cytokind, Inc. IPO soon?
No public IPO plans have been announced for Cytokind, Inc..
How can I track Cytokind, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Cytokind, Inc.'s shares on secondary markets.